Work

[18F]Fluorodeoxyglucose-PET/MRI-based response assessment following BCMA-directed CAR-T-cell therapy with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma

Year: 2026

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2026.300672

Authors: Raphael Teipel, Karolin Trautmann-Grill, Luisa Kleditsch, Katharina Epp, Sebastian Böttcher, Christoph Röllig, Heike Weidner, Andrea Gottschalk, Ingmar Glauche, Claudia Brogsitter, Ivan Platzek, Rudi Apolle, Malte von Bonin, Martin Bornhäuser, Robert Winzer, Matthias Miederer

Institutions: University Hospital Carl Gustav Carus, Technische Universität Dresden, Universitätsmedizin Rostock, German Cancer Research Center, Helmholtz-Zentrum Dresden-Rossendorf, National Center for Tumor Diseases, Nationales Centrum für Tumorerkrankungen Dresden

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: Amgen, Pfizer, Sanofi, Gilead Sciences, Technische Universität Dresden, Swedish Orphan Biovitrum, Grifols

OpenAlex ID: W7162005211

FWCI:

Cites:

Cited by:

Related to: